Page 2 - Mitchell Weiss News Today

Lead Researcher in Hematology job in Memphis, Tennessee with St. Jude Children's Research Hospital (St. Jude). Apply Today.

Lead Researcher or Scientist in Hematology - Wlodarski Lab (Bone Marrow Failure Program) job in Memphis, Tennessee with St. Jude Children's Research Hospital (St. Jude). Apply Today.

BEACON Trial of BEAM-101 in Sickle Cell Disease Progressing with Consented Patients Projected to Fill Sentinel Cohort and to Initiate Expansion Cohort First Patient Consented in Phase 1/2 Trial of...

The study explores how Gene therapy that modifies haemoglobin can help in treating sickle cell disease and beta thalassemia. | Health

Adenosine base editing restarted fetal hemoglobin expression in cells from patients with sickle cell disease. Find how St. Jude & Broad are advancing to a cure.

Gene therapy that alters hemoglobin genes may be an answer to curing sickle cell disease (SCD) and beta thalassemia.

A programmable gene editing technology called prime editing can correct the mutation that causes sickle cell disease, in a potentially curative approach.

If you think of Michelle Wu as the architect of Boston’s new city government, then Tiffany Chu ’10 might be the general contractor. As the chief of staff to Mayor Wu, Chu is in charge of figuring out how visions of urban transformation actually take shape. Take the Thursday afternoon in early February that found…

Prime-edited hematopoietic stem cells from sickle cell disease patients can engraft and help treat genetic blood disorders in mice.

New study from St. Jude Childrens, MIT and Harvard shows a promising approach to treating sickle cell disease.